Citius Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 12, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Market Capitalization	160	99	96	-
Market Cap Growth	311.83%	2.93%	-	-
Last Close Price	1.91	1.39	10.77	-
PB Ratio	4.22	2.15	3.77	-
P/TBV Ratio	4.92	2.15	3.77	-
P/OCF Ratio	1262.42	784.41	-	-
Debt / Equity Ratio	0.12	0.08	-	-
Current Ratio	0.35	0.34	0.37	0.46
Return on Equity (ROE)	-107.54%	-59.01%	-41.09%	-
Return on Assets (ROA)	-22.48%	-19.47%	-16.76%	-
Return on Capital (ROIC)	-59.84%	-34.07%	-24.52%	-
Earnings Yield	-16.66%	-21.34%	-13.19%	-
Buyback Yield / Dilution	-5.32%	-0.82%	-100.00%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q